サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：静脈内カテーテル（IVカテーテル）市場：成長、将来展望、競合分析、2024年～2032年
市場調査レポート
商品コード
1552368

静脈内カテーテル（IVカテーテル）市場：成長、将来展望、競合分析、2024年～2032年

Intravenous Catheters Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032

出版日
ページ情報
英文 171 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
静脈内カテーテル（IVカテーテル）市場：成長、将来展望、競合分析、2024年～2032年
出版日: 2024年08月28日
発行: Acute Market Reports
ページ情報: 英文 171 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈内カテーテル（IVカテーテル）は、患者の静脈系に薬物、水分、栄養分を直接送り込んだり、検査目的で血液サンプルを採取するために設計された医療機器です。これらのカテーテルは、さまざまな治療や処置において重要な役割を担っており、病院や診療所などの医療現場における定番となっています。静脈内カテーテル市場は、2024年から2032年にかけてCAGR 6.1％で成長すると予測されています。

静脈内カテーテル市場は、慢性疾患の有病率の増加、手術件数の増加、医療技術の進歩に牽引され、着実な成長を遂げています。また、心血管疾患、がん、糖尿病など、静脈内治療を必要とする慢性疾患に罹患しやすい世界人口の高齢化も、静脈内カテーテル需要に大きく寄与しています。さらに、針刺し損傷や感染症のリスクを低減するよう設計された安全カテーテルを含む、より洗練されたカテーテル技術の開発により、静脈内治療の効率性と安全性が向上しています。地域的には、市場は北米、欧州、アジア太平洋、その他の地域に区分されます。北米が市場で大きなシェアを占めているのは、先進的な医療インフラ、高額な医療費、主要な市場プレイヤーの存在によるものです。しかし、アジア太平洋地域は、医療施設の改善、医療意識の向上、慢性疾患の有病率の上昇により、急成長を遂げています。

促進要因としての慢性疾患の有病率の増加

静脈内カテーテル市場の成長は、世界の慢性疾患の有病率の上昇によって大きく後押しされています。糖尿病、がん、心血管疾患などの慢性疾患では、長期の薬剤投与、水分補給、栄養補給が必要となることが多く、静脈内カテーテルが極めて重要な役割を果たします。世界保健機関（WHO）によると、慢性疾患は世界の死亡原因のトップであり、死亡者全体の71％を占めています。このように慢性的な健康状態が深刻化しているため、静脈内カテーテルの需要が高まっています。静脈内カテーテルは治療を実施し、これらの疾患を効果的に管理するために不可欠だからです。例えば、がん治療のための化学療法では、中心静脈内カテーテルは長期間にわたって薬剤を送達するために不可欠です。

技術進歩のチャンス

静脈内カテーテル市場には、技術的進歩による大きなビジネスチャンスがあります。針刺し損傷や血流感染のリスクを低減するよう設計された安全静脈内カテーテルなどの技術革新は、医療現場で採用されるケースが増えています。また、カテーテル関連感染の減少に役立つ抗菌カテーテルの開発も大きなビジネスチャンスです。こうした進歩は患者の安全性を向上させるだけでなく、医療処置の効率も高めるため、世界中の病院や診療所で受け入れが進んでいます。

IVカテーテルのコストとメンテナンスが抑制要因

しかし、市場は静脈内カテーテルのコストとメンテナンスに起因する抑制要因に直面しています。高品質のカテーテル、特に高度な安全機能を備えたカテーテルは高価な場合があり、特に医療予算が限られている発展途上国の医療施設にとっては課題となります。さらに、IVカテーテルのメンテナンスや適切な取り扱いには、訓練を受けた医療専門家が必要であるため、運用コストがかさみ、資源に制約のある環境における市場の成長を妨げています。

カテーテル関連合併症の課題

静脈内カテーテル市場における重要な課題の1つは、感染症や血栓症などのカテーテル関連合併症の管理です。カテーテル関連血流感染（CRBSI）は深刻な懸念事項であり、罹患率の増加、入院期間の延長、医療コストの増加につながります。カテーテル技術の進歩にもかかわらず、これらの合併症のリスクは依然として重大な問題であり、カテーテルの設計や使用プロトコルを改善するための継続的な研究開発が必要です。課題は、効果的な静脈アクセスの必要性とカテーテルの長期使用に伴うリスクの最小化のバランスをとることにあります。

市場セグメンテーション：タイプ別

静脈内カテーテル市場はタイプ別に末梢カテーテル、Midline末梢カテーテル、中心静脈内カテーテルに区分され、それぞれが特定の臨床ニーズに対応しています。末梢カテーテルは短期間の薬物投与に一般的に使用され、即時の静脈アクセスのためにさまざまな医療現場で広く使用されているため、市場収益をリードしています。その普及は、急性期医療における輸液療法から薬物投与に至るまで、その用途が日常的であることに起因しています。中央静脈カテーテルは、化学療法や完全非経口栄養療法などの長期使用を目的として設計されており、年間平均成長率（CAGR）が最も高くなると予想されています。

静脈内カテーテル市場

長期の治療を必要とする慢性疾患の有病率の増加と、複雑な治療における中心静脈内カテーテルの選好の高まりがこの成長を牽引しています。末梢静脈内カテーテルと中心静脈内カテーテルの中間的な役割を果たすミッドライン末梢カテーテルも、中期的な静脈内治療における有用性から人気を集めています。

地域別の洞察

静脈内カテーテル市場の地域別市場分析では、明確な地域動向と成長の可能性が観察されます。2023年には、北米が最も高い売上比率を占めたが、これは高度な医療インフラ、高い医療費、先進医療技術の普及といった要因に影響されたものです。同地域の市場優位性は、慢性疾患の罹患率の高さと、それに伴う治療や薬剤投与のための静脈内カテーテル留置の必要性にも支えられています。しかし、2024年から2032年にかけては、アジア太平洋地域の年間平均成長率（CAGR）が最も高くなると予想されています。このような成長が予想される背景には、医療費の増加、先進医療に対する意識の高まり、中国やインドなどの新興国における静脈内治療を必要とする疾患の有病率の増加があります。さらに、医療インフラを改善するための政府の取り組みや、これらの地域における主要市場プレイヤーのプレゼンス拡大も、この成長軌道に寄与しています。

競合動向

競合動向と戦略に関して、IVカテーテル市場は多様なプレーヤーとアプローチを包含しています。2023年には、Becton, Dickinson and Company（BD）、B. Braun Melsungen AG、Terumo Corporationなどの主要企業、Mediplus India Ltd、Sterimed Group、Medilivescare Manufacturing Pvt. Ltd、Angiplast Pvt Ltd、Teleflex Incorporated、Nipro Europe Group Companies、Cook、ICU Medical, Inc.、TuCann Medicalなどが市場の収益に貢献しました。これらの企業はこれまで、市場での地位を維持するために技術革新と拡大戦略に注力してきました。

本レポートでお答えする主な質問

静脈内カテーテル市場の成長に影響を与える主要なミクロおよびマクロ環境要因は何か？

現在および予測期間中の製品セグメントと地域に関する主な投資ポケットは？

2032年までの推定推計・市場予測

予測期間中にCAGRが最も速いセグメントは？

市場シェアの大きいセグメントとその理由は？

中低所得国は静脈内カテーテル市場に投資しているか？

静脈内カテーテル市場で最大の地域市場はどこか？

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と力学は？

静脈内カテーテル市場の成長を促進する主要動向は？

世界の静脈内カテーテル市場で存在感を高めるための主要な競合企業とその主要戦略とは？

目次

第1章 序文

  • レポート内容
    • レポートの目的
    • 対象者
    • 主な提供
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 静脈内カテーテル市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用した戦略
  • 主要な産業戦略
  • ティア分析：2023 vs 2032

第4章 静脈内カテーテル市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の静脈内カテーテル市場金額、2022-2032年
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーパワー
    • バイヤーパワー
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治情勢
    • 経済情勢
    • 技術情勢
    • 法的情勢
    • 社会情勢

第5章 静脈内カテーテル市場：タイプ別、2022-2032年

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 市場セグメンテーション
    • 末梢カテーテル
    • Midline末梢カテーテル
    • 中心静脈カテーテル（CVC）

第6章 静脈内カテーテル市場：最終用途別、2022-2032年

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 市場セグメンテーション
    • 病院薬局
    • 小売薬局
    • その他

第7章 北米の静脈内カテーテル市場、2022-2032年

  • 市場概要
  • 静脈内カテーテル市場：タイプ別、2022-2032年
  • 静脈内カテーテル市場：最終用途別、2022-2032年
  • 静脈内カテーテル市場：地域別、2022-2032年
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第8章 英国・欧州連合の静脈内カテーテル市場、2022-2032年

  • 市場概要
  • 静脈内カテーテル市場：タイプ別、2022-2032年
  • 静脈内カテーテル市場：最終用途別、2022-2032年
  • 静脈内カテーテル市場：地域別、2022-2032年
    • 英国・欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第9章 アジア太平洋の静脈内カテーテル市場、2022-2032年

  • 市場概要
  • 静脈内カテーテル市場：タイプ別、2022-2032年
  • 静脈内カテーテル市場：最終用途別、2022-2032年
  • 静脈内カテーテル市場：地域別、2022-2032年
    • アジア太平洋地域
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第10章 ラテンアメリカの静脈内カテーテル市場、2022-2032年

  • 市場概要
  • 静脈内カテーテル市場：タイプ別、2022-2032年
  • 静脈内カテーテル市場：最終用途別、2022-2032年
  • 静脈内カテーテル市場：地域別、2022-2032年
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第11章 中東・アフリカの静脈内カテーテル市場、2022-2032年

  • 市場概要
  • 静脈内カテーテル市場：タイプ別、2022-2032年
  • 静脈内カテーテル市場：最終用途別、2022-2032年
  • 静脈内カテーテル市場：地域別、2022-2032年
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第12章 企業プロファイル

  • Boston Scientific Corporation
  • BD
  • B. Braun SE
  • Mediplus India Ltd
  • Sterimed Group
  • Medilivescare Manufacturing Pvt. Ltd.
  • Angiplast Pvt Ltd.
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Nipro Europe Group Companies
  • Cook
  • ICU Medical Inc.
  • TuCann Medical
  • その他の主要企業
図表

List of Tables

  • TABLE 1 Global Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 2 Global Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 3 North America Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 4 North America Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 5 U.S. Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 6 U.S. Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 7 Canada Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 8 Canada Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 9 Rest of North America Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 10 Rest of North America Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 11 UK and European Union Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 12 UK and European Union Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 13 UK Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 14 UK Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 15 Germany Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 16 Germany Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 17 Spain Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 18 Spain Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 19 Italy Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 20 Italy Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 21 France Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 22 France Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 23 Rest of Europe Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 24 Rest of Europe Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 25 Asia Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 26 Asia Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 27 China Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 28 China Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 29 Japan Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 30 Japan Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 31 India Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 32 India Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 33 Australia Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 34 Australia Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 35 South Korea Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 36 South Korea Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 37 Latin America Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 38 Latin America Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 39 Brazil Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 40 Brazil Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 41 Mexico Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 42 Mexico Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 43 Rest of Latin America Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 44 Rest of Latin America Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 45 Middle East and Africa Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 46 Middle East and Africa Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 47 GCC Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 48 GCC Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 49 Africa Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 50 Africa Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Intravenous Catheters Market By Type, 2022-2032, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Intravenous Catheters Market By End-Use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Intravenous Catheters Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Intravenous Catheters Market: Quality Assurance
  • FIG. 5 Global Intravenous Catheters Market, By Type, 2023
  • FIG. 6 Global Intravenous Catheters Market, By End-Use, 2023
  • FIG. 7 Global Intravenous Catheters Market, By Geography, 2023
  • FIG. 8 Market Geographical Opportunity Matrix - Global Intravenous Catheters Market, 2023

FIG. 9Market Positioning of Key Intravenous Catheters Market Players, 2023

FIG. 10Global Intravenous Catheters Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 11 Global Intravenous Catheters Market, By Type, 2023 Vs 2032, %
  • FIG. 12 Global Intravenous Catheters Market, By End-Use, 2023 Vs 2032, %
  • FIG. 13 U.S. Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 14 Canada Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 15 Rest of North America Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 16 UK Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 17 Germany Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 18 Spain Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 19 Italy Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 20 France Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 21 Rest of Europe Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 22 China Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 23 Japan Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 24 India Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 25 Australia Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 26 South Korea Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 27 Rest of Asia Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 28 Brazil Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 29 Mexico Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 30 Rest of Latin America Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 31 GCC Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 32 Africa Intravenous Catheters Market (US$ Million), 2022 - 2032
  • FIG. 33 Rest of Middle East and Africa Intravenous Catheters Market (US$ Million), 2022 - 2032
目次
Product Code: 391-07-24

Intravenous (IV) catheters are medical devices designed for delivering medications, fluids, and nutrients directly into a patient's venous system and for drawing blood samples for testing purposes. These catheters play a critical role in a wide range of medical treatments and procedures, making them a staple in hospitals, clinics, and other healthcare settings. The intravenous catheters market is growing is estimated to grow at a CAGR of 6.1% from 2024 to 2032.

The market for intravenous catheters has witnessed steady growth, driven by the increasing prevalence of chronic diseases, the rising number of surgical procedures, and advancements in medical technology. The aging global population, which is more prone to chronic conditions requiring IV therapy, such as cardiovascular diseases, cancer, and diabetes, also significantly contributes to the demand for IV catheters. Furthermore, the development of more sophisticated catheter technologies, including safety catheters designed to reduce the risk of needlestick injuries and infections, has enhanced the efficiency and safety of intravenous therapy. Geographically, the market is segmented across North America, Europe, Asia-Pacific, and other regions. North America holds a significant share of the market, attributed to its advanced healthcare infrastructure, high healthcare spending, and the presence of key market players. However, the Asia-Pacific region is witnessing rapid growth due to improving healthcare facilities, increasing healthcare awareness, and the rising prevalence of chronic diseases.

Increasing Prevalence of Chronic Diseases as a Driver

The growth of the intravenous (IV) catheters market is significantly propelled by the rising prevalence of chronic diseases worldwide. Chronic conditions such as diabetes, cancer, and cardiovascular diseases often necessitate long-term medication administration, hydration, and nutrition, where IV catheters play a pivotal role. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality globally, accounting for 71% of all deaths. This escalation in chronic health conditions increases the demand for IV catheters, as they are essential for administering treatments and managing these diseases effectively. For example, in chemotherapy for cancer treatment, central venous catheters are indispensable for delivering drugs over an extended period.

Opportunity in Technological Advancements

The IV catheters market presents substantial opportunities through technological advancements. Innovations such as safety IV catheters, designed to reduce needlestick injuries and the risk of bloodstream infections, are increasingly being adopted in healthcare settings. The development of antimicrobial catheters, which help in reducing catheter-related infections, also represents a significant opportunity. These advancements not only improve patient safety but also enhance the efficiency of medical procedures, leading to their growing acceptance in hospitals and clinics worldwide.

Cost and Maintenance of IV Catheters as a Restraint

However, the market faces restraints due to the cost and maintenance associated with IV catheters. High-quality catheters, particularly those with advanced safety features, can be expensive, posing a challenge for healthcare facilities, especially in developing countries with limited healthcare budgets. Furthermore, the maintenance and proper handling of IV catheters, requiring trained healthcare professionals, add to the operational costs, thus hindering the market's growth in resource-constrained settings.

Challenge of Catheter-Related Complications

One significant challenge in the IV catheters market is managing catheter-related complications, such as infections and thrombosis. Catheter-related bloodstream infections (CRBSIs) are a serious concern, leading to increased morbidity, extended hospital stays, and higher healthcare costs. Despite advancements in catheter technology, the risk of these complications remains a critical issue, necessitating ongoing research and development to improve catheter designs and usage protocols. The challenge lies in balancing the need for effective intravenous access with minimizing the risks associated with long-term catheter use.

Market Segmentation by Type

The intravenous (IV) catheters market is segmented by type into peripheral catheters, midline peripheral catheters, and central venous catheters, each serving specific clinical needs. Peripheral catheters, commonly used for short-term medication administration, lead in market revenue due to their widespread use in various medical settings for immediate venous access. Their prevalence is attributed to the routine nature of their applications, ranging from fluid therapy to medication delivery in acute care. Central venous catheters, designed for long-term use, such as in chemotherapy or total parenteral nutrition, are anticipated to register the highest Compound Annual Growth Rate (CAGR).

The intravenous (IV) catheters market

This growth is driven by the increasing prevalence of chronic diseases requiring prolonged treatments and the growing preference for central venous catheters in complex medical treatments. Midline peripheral catheters, serving as a middle ground between peripheral and central venous catheters, are also gaining popularity for their utility in medium-term intravenous therapy.

Regional Insights

In the geographic analysis of the intravenous (IV) catheters market, distinct regional trends and growth potentials are observed. In 2023, North America held the highest revenue percentage, a position influenced by factors like advanced healthcare infrastructure, high healthcare expenditure, and the prevalent use of advanced medical technologies. The region's market dominance was also supported by the high incidence of chronic diseases and the consequent need for IV catheterization for treatment and drug administration. However, looking ahead from 2024 to 2032, the Asia-Pacific region is expected to experience the highest Compound Annual Growth Rate (CAGR). This anticipated growth is attributed to the increasing healthcare expenditures, rising awareness of advanced medical treatments, and the growing prevalence of diseases requiring IV therapy in emerging economies such as China and India. Additionally, government initiatives to improve healthcare infrastructure and the expanding presence of key market players in these regions contribute to this growth trajectory.

Competitive trends

In terms of competitive trends and strategies, the IV catheters market encompasses a diverse array of players and approaches. In 2023, leading companies like Becton, Dickinson and Company (BD), B. Braun Melsungen AG, and Terumo Corporation, Mediplus India Ltd, Sterimed Group, Medilivescare Manufacturing Pvt. Ltd., Angiplast Pvt Ltd., Teleflex Incorporated, Nipro Europe Group Companies, Cook, ICU Medical, Inc., and TuCann Medical were notable contributors to the market's revenue. These companies have historically focused on innovation and expansion strategies to maintain their market positions. For instance, BD's emphasis on developing safety IV catheters and B. Braun's focus on user-friendly catheter designs have set them apart in the market. Terumo Corporation has also made significant strides, particularly in expanding its product range and geographic reach. From 2024 to 2032, these companies, along with emerging players, are expected to continue focusing on strategic collaborations, mergers, and acquisitions to enhance their market presence. The market is also likely to witness increased investment in research and development to introduce more advanced and patient-friendly IV catheter products. This competitive landscape highlights the dynamic and innovative nature of the IV catheters market, where evolving healthcare needs and technological advancements drive growth and strategic shifts among key players.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Intravenous Catheters market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Intravenous Catheters market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Type

    • Peripheral Catheters
    • Midline Peripheral Catheters
    • Central Venous Catheters

End-Use

    • Hospital Pharmacies
    • Retail Pharmacies
    • Others

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Intravenous Catheters market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Intravenous Catheters market?

Which is the largest regional market for Intravenous Catheters market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Intravenous Catheters market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Intravenous Catheters market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Intravenous Catheters Market
  • 2.2. Global Intravenous Catheters Market, By Type, 2023 (US$ Million)
  • 2.3. Global Intravenous Catheters Market, By End-Use, 2023 (US$ Million)
  • 2.4. Global Intravenous Catheters Market, By Geography, 2023 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2023

3. Intravenous Catheters Market: Competitive Analysis

  • 3.1. Market Positioning of Key Intravenous Catheters Market Vendors
  • 3.2. Strategies Adopted by Intravenous Catheters Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Intravenous Catheters Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Intravenous Catheters Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Peripheral Catheters
    • 5.3.2. Midline Peripheral Catheters
    • 5.3.3. Central Venous Catheters

6. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Hospital Pharmacies
    • 6.3.2. Retail Pharmacies
    • 6.3.3. Others

7. North America Intravenous Catheters Market, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
  • 7.3. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
  • 7.4.Intravenous Catheters Market: By Region, 2022-2032, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 7.4.1.1.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 7.4.1.2.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 7.4.1.3.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)

8. UK and European Union Intravenous Catheters Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
  • 8.3. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
  • 8.4.Intravenous Catheters Market: By Region, 2022-2032, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 8.4.1.1.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 8.4.1.2.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 8.4.1.3.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 8.4.1.4.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 8.4.1.5.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 8.4.1.6.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)

9. Asia Pacific Intravenous Catheters Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
  • 9.3. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
  • 9.4.Intravenous Catheters Market: By Region, 2022-2032, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 9.4.1.1.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 9.4.1.2.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 9.4.1.3.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 9.4.1.4.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 9.4.1.5.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 9.4.1.6.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)

10. Latin America Intravenous Catheters Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
  • 10.3. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
  • 10.4.Intravenous Catheters Market: By Region, 2022-2032, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 10.4.1.1.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 10.4.1.2.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 10.4.1.3.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)

11. Middle East and Africa Intravenous Catheters Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
  • 11.3. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
  • 11.4.Intravenous Catheters Market: By Region, 2022-2032, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 11.4.1.1.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 11.4.1.2.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Intravenous Catheters Market: By Type, 2022-2032, USD (Million)
        • 11.4.1.3.2. Intravenous Catheters Market: By End-Use, 2022-2032, USD (Million)

12. Company Profile

  • 12.1. Boston Scientific Corporation
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. BD
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. B. Braun SE
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Mediplus India Ltd
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Sterimed Group
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Medilivescare Manufacturing Pvt. Ltd.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Angiplast Pvt Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Teleflex Incorporated
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Terumo Medical Corporation
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Nipro Europe Group Companies
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Cook
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. ICU Medical, Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives
  • 12.13. TuCann Medical
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Portfolio
    • 12.13.4. Strategic Initiatives
  • 12.14. Other Notable Players
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Portfolio
    • 12.14.4. Strategic Initiatives